Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FAKKY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,283
Award facts
- Contract value 100% obligated
- $39,282.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $39,282.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL format, with an ultimate completion date of January 12, 2026. This non-set-aside contract, awarded on January 9, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across the Defense Health System and other government healthcare entities.
This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. Cosentyx is a specialty immunosuppressant medication used in treating various autoimmune conditions, and its procurement through the DLA supply chain ensures availability for military treatment facilities and other federal medical institutions requiring this therapeutic agent.
Quick answers
Who was awarded contract SPE2DR26FAKKY?
SPE2DR26FAKKY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FAKKY worth?
The government has obligated $39,283 on SPE2DR26FAKKY.
Is contract SPE2DR26FAKKY an order under another contract?
Yes. SPE2DR26FAKKY is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKKY competed?
The extent of competition for SPE2DR26FAKKY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award